NewSquare Capital LLC Grows Stake in Sanofi (NASDAQ:SNY)

NewSquare Capital LLC lifted its holdings in shares of Sanofi (NASDAQ:SNY) by 3.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 106,697 shares of the company’s stock after buying an additional 3,723 shares during the quarter. NewSquare Capital LLC’s holdings in Sanofi were worth $5,239,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of SNY. Morgan Stanley increased its holdings in Sanofi by 4.6% during the 3rd quarter. Morgan Stanley now owns 7,322,806 shares of the company’s stock worth $392,796,000 after acquiring an additional 323,968 shares during the period. Envestnet Asset Management Inc. increased its holdings in Sanofi by 29.8% during the 3rd quarter. Envestnet Asset Management Inc. now owns 2,838,903 shares of the company’s stock worth $152,279,000 after acquiring an additional 651,756 shares during the period. Natixis Advisors L.P. increased its holdings in Sanofi by 15.9% during the 3rd quarter. Natixis Advisors L.P. now owns 2,528,289 shares of the company’s stock worth $135,618,000 after acquiring an additional 346,563 shares during the period. Raymond James & Associates increased its holdings in Sanofi by 1.5% during the 3rd quarter. Raymond James & Associates now owns 2,096,142 shares of the company’s stock worth $112,437,000 after acquiring an additional 31,773 shares during the period. Finally, American Century Companies Inc. increased its holdings in Sanofi by 1.0% during the 3rd quarter. American Century Companies Inc. now owns 1,472,190 shares of the company’s stock worth $78,968,000 after acquiring an additional 15,154 shares during the period. 10.04% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

SNY has been the topic of a number of analyst reports. TheStreet lowered shares of Sanofi from a “b” rating to a “c” rating in a report on Friday, February 9th. Morgan Stanley initiated coverage on shares of Sanofi in a report on Tuesday, January 23rd. They issued an “equal weight” rating and a $55.00 price target on the stock. Finally, StockNews.com lowered shares of Sanofi from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 27th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Sanofi presently has a consensus rating of “Hold” and an average target price of $55.00.

Sanofi Price Performance

Shares of NASDAQ:SNY traded up $0.54 during trading on Tuesday, reaching $47.69. The company had a trading volume of 1,664,859 shares, compared to its average volume of 1,914,748. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.19. Sanofi has a 12 month low of $42.63 and a 12 month high of $57.82. The company has a fifty day moving average of $47.58 and a two-hundred day moving average of $48.45. The stock has a market capitalization of $120.64 billion, a P/E ratio of 20.21, a price-to-earnings-growth ratio of 1.62 and a beta of 0.61.

Sanofi (NASDAQ:SNY) last released its earnings results on Thursday, February 1st. The company reported $0.89 EPS for the quarter, missing the consensus estimate of $0.94 by ($0.05). Sanofi had a net margin of 12.56% and a return on equity of 27.47%. The business had revenue of $11.76 billion for the quarter, compared to the consensus estimate of $13.02 billion. Equities research analysts forecast that Sanofi will post 4.11 earnings per share for the current year.

Sanofi Increases Dividend

The firm also recently announced an annual dividend, which will be paid on Thursday, June 6th. Investors of record on Friday, May 10th will be issued a dividend of $1.478 per share. The ex-dividend date is Thursday, May 9th. This represents a dividend yield of 2.98%. This is a positive change from Sanofi’s previous annual dividend of $1.38. Sanofi’s dividend payout ratio (DPR) is currently 58.47%.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.